Echo IQ confirms receipt of R&D Tax Incentive

Echo IQ Limited (ASX: $EIQ) has confirmed the receipt of $1,267,655.44 under the Australian Government's Research and Development Tax Incentive Scheme for the financial year ended 30 June 2023. The incentive is in recognition of the company's expenditure on research and development related to its artificial intelligence innovation and the development of decision-support solutions for the detection of structural heart disease.

Executive Commentary on R&D Tax Incentive

We are pleased to confirm the receipt of the Research and Development Tax Incentive for the financial year 2023. This incentive reflects the government's support for businesses engaged in innovative research and development activities. The funds received will further contribute to our ongoing efforts in advancing artificial intelligence technology and developing solutions for the detection of structural heart disease.

Summary of R&D Tax Incentive Receipt

Echo IQ Limited (ASX: $EIQ) has received $1,267,655.44 under the Australian Government's Research and Development Tax Incentive Scheme for the financial year ended 30 June 2023. The company's focus on artificial intelligence innovation and the development of decision-support solutions for the detection of structural heart disease has been recognized through this incentive. The receipt of the R&D tax incentive underscores the government's commitment to fostering technological advancements in the medical field. This financial support will aid Echo IQ in its continued pursuit of pioneering AI-driven technology and software to enhance decision-making in cardiology.